Description and Brand Names
Información sobre medicamentos proporcionada por: IBM Micromedex
US Brand Name
Crizanlizumab-tmca injection is used to prevent vaso-occlusive crisis in patients with sickle cell disease. Vaso-occlusive crisis is a common and painful complication of sickle cell disease that occurs when blood circulation is blocked by sickled red blood cells and may lead to organ damage.
This medicine is to be given only by or under the direct supervision of your doctor.
This product is available in the following dosage forms: